Guo Hui Ji

Zhejiang Jinhua Conba Bio-Pharm Co., Ltd. engages in the production and sale of medicine and vaccines. Its products include tablets, hard capsules, powder injection, freeze-dried powder injection, granules, pharmaceutical chemical intermediates, and raw materials. It also provides biotechnology development services. The company was founded in 1958 and is headquartered in Jinhua, China.

InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany.

Jiangxi Herbi-Sky Co., Ltd. engages in the manufacturing and sale of small volume injection, tablets, hard capsules, granules, tea, pills, chinese herbal pieces, and oral solution. The company was founded on December 31, 2002 and is headquartered in Yingtan, China.

University of Hong Kong School of Professional and Continuing Education engages in the educational services. It providing learning opportunities for personal, professional and career advancement for people from all walks of life. The company was founded in 1957 and is headquartered in Hong Kong.

1919 Wine & Spirits Platform Science & Technology Co., Ltd. operates an online to offline liquor business platform. Its business segments include supply chain system, control and supporting system, platform system, and business system. It offers wine, and other alcoholic products. The company was founded by LingJiang Yang in 1998 and is headquartered in Chengdu, China.

Zhejiang Kangnuobang Health Products Co., Ltd. is a Chinese biotechnology company founded in 2006. The location of the company is Hangzhou, China. The company operates in the health products industry.

Zhejiang Staidson Investment Co., Ltd. engages in investment industry. It services include Industrial Investment, Investment Management, Investment Consulting, and Business Management Consulting. The company was founded on June 27, 2017 and is headquartered in Zhejiang, China.

Staidson Biopharma, Inc. is an American company that focuses on researching and developing biotechnology.

Part of Staidson (Beijing) Biopharmaceuticals Co., Ltd., Staidson Hong Kong Investment Co. Ltd. provides asset management services. The company is based in Hong Kong, Hong Kong. Li Na Ma has been the CEO of the Chinese company since 2015.